OrbiMed portfolio

OrbiMed (Venture capital) is known to hold 197 companies, 74 of them startups. 42 of them are hiring now, with 282 open roles. Its companies closed 19 venture rounds in 12 months, raising $1.4B. Most of them work in Drug Discovery, Oncology Therapeutics, Biologics & Biosimilars.

Source: Alion Venture capital Oct 26, 2026

Investments

197

74 of them startups

Hiring now

42

282 open roles

Rounds in 12 months

19

$1.4B raised

Exits

57

Companies OrbiMed has invested in

All 197 Hiring now 42 Exits 57

Thlsq Video Surveillance · Israel Venture round $3.3M · 9 mo ago portfolio pageSep 25

BlossomHill Therapeutics Oncology Therapeutics · United States Venture round $84.2M · 11 mo ago 3 roles portfolio pageSep 25

Traws Pharma United States Venture round $14M · 2 yr ago portfolio pageSep 25

Enliven Therapeutics Drug Discovery · United States Venture round $90M · 2 yr ago portfolio pageSep 25

BioAge Labs Drug Discovery · United States Venture round $194.4M · 2 yr ago 3 roles portfolio pageSep 25

ImageneBio Immunology & Inflammation Therapeutics · United States Venture round $42.6M · 3 yr ago portfolio pageSep 25

mdxhealth Diagnostic Tests & IVD · Belgium Venture round $5M · 4 yr ago portfolio pageSep 25

Neurelis APIs & Drug Manufacturing · United States Venture round $114.8M · 5 yr ago 3 roles portfolio pageSep 25

Variantyx - Genomics & Genetic Testing · United States Venture round $15.6M · 5 yr ago portfolio pageSep 25

page United States Venture round $55k · 6 yr ago portfolio pageSep 25

Prelude Therapeutics Oncology Therapeutics · United States Venture round $50M · 6 yr ago 2 roles portfolio pageSep 25

Perfuse Therapeutics United States Venture round $9M · 6 yr ago portfolio pageSep 25

Compass Therapeutics Drug Discovery · United States Venture round $60.5M · 6 yr ago 3 roles portfolio pageSep 25

Shattuck Labs Immunology & Inflammation Therapeutics · United States Venture round $83M · 6 yr ago 2 roles portfolio pageSep 25

Emergent BioSolutions Public Health & Prevention · United States Venture round $47.9M · 8 yr ago 14 roles portfolio pageSep 25

Starling Oncology Cancer Care Centers · United States 22 roles portfolio pageSep 25

Myriad Genetics Genomics & Genetic Testing · United States 21 roles portfolio pageSep 25

Disc Medicine United States 15 roles portfolio pageSep 25

Edgewise Therapeutics United States 13 roles portfolio pageSep 25

Keros Therapeutics United States 13 roles portfolio pageSep 25

NeuroPace Neurotech & Neuromodulation · United States 12 roles portfolio pageSep 25

MBX Biosciences Cardiometabolic Therapeutics · United States 12 roles portfolio pageSep 25

ADARx Pharmaceuticals Drug Discovery · United States 6 roles portfolio pageSep 25

Lexeo Therapeutics Rare Disease Therapeutics · United States 7 roles portfolio pageSep 25

Aura Biosciences Drug Discovery · United States 3 roles portfolio pageSep 25

MDClone Synthetic Data · Israel 3 roles portfolio pageSep 25

Trisalus Life Sciences Drug Discovery · United States 2 roles portfolio pageSep 25

Verrica Pharmaceuticals Dermatology · United States 2 roles portfolio pageSep 25

Adicet Bio Oncology Therapeutics · United States 1 role portfolio pageSep 25

Crinetics Drug Discovery · United States 1 role portfolio pageSep 25

Adcendo Biologics & Biosimilars portfolio pageSep 25

ArriVent BioPharma portfolio pageSep 25

Aspen Neuroscience Cell & Gene Therapy portfolio pageSep 25

AvaloTx portfolio pageSep 25

Brenig Therapeutics, Inc. Neurology & CNS Therapeutics portfolio pageSep 25

Chemomab Drug Discovery portfolio pageSep 25

EC Healthcare Precision Medicine portfolio pageSep 25

Electra Therapeutics portfolio pageSep 25

ENYO Pharma portfolio pageSep 25

iECURE Cell & Gene Therapy portfolio pageSep 25

Insmed portfolio pageSep 25

Inventisbio portfolio pageSep 25

Laekna portfolio pageSep 25

Marksans Pharma Prescription Drugs portfolio pageSep 25

MinervaX Vaccines portfolio pageSep 25

Nucleix portfolio pageSep 25

Nucleus RadioPharma APIs & Drug Manufacturing portfolio pageSep 25

Odyssey Immunology & Inflammation Therapeutics · United States portfolio pageSep 25

OnCusp Therapeutics, Inc. portfolio pageSep 25

Pathalys Pharma, Inc. Biologics & Biosimilars portfolio pageSep 25

Q32 Bio portfolio pageSep 25

Scribe 2026 Privacy Policy Site by Bunsen United States portfolio pageSep 25

sionna_tx portfolio pageSep 25

Suraksha Diagnostic Limited Psychotherapy & Counseling portfolio pageSep 25

Upstream Bio portfolio pageSep 25

Z-Alpha Therapeutics portfolio pageOct 2

ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD. Health & Medical Electronics · Hong Kong portfolio pageSep 25

Open roles at OrbiMed portfolio companies

Senior Executive Assistant, CommercialDisc Medicine · this month Fullstack Engineer - IIIKapiva · this month

Senior Research Associate, Assay Development (Contract)DELFI Diagnostics · this month

Clinical Laboratory Scientist - PM Shift (Contract)DELFI Diagnostics · this month SDE IIIKapiva · this month

Clinical Trial ManagerPrelude Therapeutics · this month

Patient Activation Specialist (Fargo, North Dakota)Noctrix Health · this month Staff Biomedical Data ManagerPathai · this month

Director, Brand MarketingDisc Medicine · this month

Payroll SpecialistMBX Biosciences · this month

Information Technology ManagerMagenta Med · this month

Clinical Scientist, ContractorAura Biosciences · this month Staff Software Engineer, FullstackPathai · this month

Data Engineer IIIMyriad Genetics · this month

Executive Director, Commercial PlanningDisc Medicine · this month

Clinical Data Manager IICompass Therapeutics · this month

Scientist I/II, Modality EngineeringLexeo Therapeutics · this month

Scientist I/II, In Vivo PharmacologyLexeo Therapeutics · this month

Director, Clinical Operations (Obesity)MBX Biosciences · this month

Computer System Validation Specialist (CSV) - MedPharmMedPharm · this month

282 open roles at 42 of its companies

Focus

Markets

Drug Discovery11%

Oncology Therapeutics7%

Biologics & Biosimilars4%

Immunology & Inflammation Therapeutics3%

Cell & Gene Therapy3%

Vaccines3%

Rare Disease Therapeutics3%

Genomics & Genetic Testing2%

Where its companies are

United States29%

China4%

India3%

Israel2%

United Kingdom1%

Belgium1%

Switzerland1%

Hong Kong1%

Stage of its companies

Venture, series not stated70%

Series A12%

Series B10%

Series C and later7%

Co-investors

RA Capital Management21 shared

Foresite Capital12 shared

SR One9 shared

Wellington Management7 shared

NEA7 shared

Atlas Venture7 shared

F-Prime Capital6 shared

Longitude Capital6 shared

LAV6 shared

HBM Healthcare Investments6 shared

Similar investors

their companies share markets and countries

ARCH Venture Partners

RA Capital Management

Longitude Capital

Sofinnova Investments

Questions about OrbiMed

How many companies has OrbiMed invested in?

OrbiMed is known to hold 197 companies: 74 startups, and 57 exits so far, read from its own portfolio page and the funding rounds that name it.

Is OrbiMed investing now?

OrbiMed has no round in the press in 12 months and no new company on its portfolio page in 90 days.

What does OrbiMed invest in?

The markets of the companies OrbiMed holds: Drug Discovery (11%), Oncology Therapeutics (7%), Biologics & Biosimilars (4%), Immunology & Inflammation Therapeutics (3%), Cell & Gene Therapy (3%).

Which OrbiMed portfolio companies are hiring?

42 companies OrbiMed holds are hiring now, with 282 open roles listed on this page.

Who does OrbiMed invest alongside?

The investors that hold the most companies together with OrbiMed: RA Capital Management, Foresite Capital, SR One, Wellington Management, NEA.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 25; 3 rounds in the press that name it

OrbiMed portfolio: 197 known companies. Alion, Oct 26, 2026. https://alion.io/company/orbimed/portfolio

Licence: CC BY-SA 4.0JSON